The US Food and Drug Administration (FDA) has given approval for Medtronic‘s CapSureFix Novus MRI SureScan 5076 lead, which will be used with magnetic resonance imaging (MRI).

The lead can be positioned on any region of the body when paired with the firm’s dual-chamber MR-conditional pacemaker.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Earlier this year, the 5076 lead was approved for use with the company’s non-MR-conditional pacemakers, which was well-received because of its handling and proven reliability, the company said.

"The new approval allows two 5076 MRI leads to be paired with dual-chamber Medtronic Advisa MRI or Revo MRI SureScan pacemakers, which helps patients to undergo full-body MRI scans."

The new approval allows two 5076 MRI leads to be paired with dual-chamber Medtronic Advisa MRI or Revo MRI SureScan pacemakers, which helps patients to undergo full-body MRI scans.

The company noted that 5076 MRI lead lengths approved for these scans range in length from 35cm to 85cm.

See Also:

Medtronic bradycardia business vice-president Brian Urke said: "The 5076 lead has proven to be one of the most reliable pacing leads for more than a decade, and due to extensive testing, now also can undergo MRI scans.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"This is especially important for patients who need MRIs and received 5076 leads at the time of their initial implants; although they may not have received MR-conditional pacemakers initially, they now have the option to get a pacemaker approved for MRI when they require a device change-out, making the entire system MR-conditional."

Patients who previously had two 5076 leads implanted with non-MRI pacemakers will have the option to receive MRIs if MR-conditional SureScan pacemakers are implanted when replacement devices are needed, the company said.

The company also produces SureScan neurostimulation systems for the management of chronic pain, and the SynchroMed II programmable drug infusion system.